The global automated cell counter market size is calculated at USD 7.23 billion in 2025 and is forecasted to reach around USD 11.77 billion by 2034, accelerating at a CAGR of 5.58% from 2025 to 2034. The North America automated cell counter market size surpassed USD 4.10 billion in 2024 and is expanding at a CAGR of 5.67% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Automated Cell Counter Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Automated Cell Counter Market Revenue and Volume, by Product Type
8.1.1 Fluorescence Image-based Counter
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Flow Cytometer
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Coulter Counter
8.1.3.1. Market Revenue and Volume Forecast
9.1. Automated Cell Counter Market Revenue and Volume, by Application
9.1.1. Blood Cells
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Cell Lines
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Microbial Cells
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast
10.1. Automated Cell Counter Market Revenue and Volume, by End-user
10.1.1. Pharmaceuticals and Biotechnology Companies
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Diagnostics Laboratories
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Research Institutes
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End-user
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End-user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End-user
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End-user
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End-user
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End-user
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End-user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End-user
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End-user
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End-user
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End-user
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End-user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End-user
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End-user
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End-user
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End-user
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End-user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End-user
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End-user
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End-user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End-user
12.1. Eppendorf
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merck KGaA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Sysmex Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Tecan Group
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Thermo Fisher Scientific
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bio-Rad Laboratories
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Logos Biosystems
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Abbott
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. PerkinElmer Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Olympus Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample